pharmacogenomics

  • Home
  • Tag: pharmacogenomics

Advancements in Nanopore HLA Testing for Pharmacogenomics

Thidathip Wongsurawat presented at London Calling 2025 on “Nanopore-based HLA testing: a rising star driving real-world clinical implementation in pharmacogenomics.” Wongsurawat is from Mahidol university in Thailand. Wongsurawat has been using nanopore sequencing since 2017 and moved back to her hometown after doing research in the US. Now they work with a company and set […]
Read more

The Significance of Long Reads in Determining Intronic Mutations

Today, I watched another London Calling 2024 studio interview. Zoe McDougall interviewed three speakers. Tom Walsh from the University of Washington spoke about how long reads are important to determine intronic mutations. The full locus of BRCA1 is over 100 kb, and intronic mutations can occur with significant implications. Mike Clark from the University of […]
Read more

Pharmacogenomics in the Era of Long-read Sequencing and Adaptive Sampling

Koen Deserranno from Ghent University in Belgium presented a lightning talk at London Calling 2023. The title was “Advancing targeted haplotyping in pharmacogenomics using adaptive sampling.” For example, they explained that pharmacogenomics studies the genetic impact on drug efficiency. There is a need for long-read sequencing for some pharco genes. The current pharmacogenomics information, Deserranno […]
Read more

NCM Singapore 2023 Applications Update

Tonight I watched Dan Turner, SVP of Applications at Oxford Nanopore Technologies (ONT) give an update from the applications team at the Nanopore Community Meeting in Singapore. Turner talked about the applications team with researchers and groups in Singapore, the UK, and a couple other locations. Turner focused on Nanopore use for Pharmacogenomics (PGx). They […]
Read more

Improved Pharmacogenomics with Adaptive Sampling

Tonight I watched the London Calling 2023 session entitled “Advancing targeted haplotyping in pharmacogenomics using adaptive sampling.” Koen Deserranno from Ghent University in Belgium spoke about their research. They are a pharmacist by training and are interested in pharmacogenomics (PGx): personalization of drug therapy based on genomic sequences of the individual. Deserranno spoke about how […]
Read more